SoftBank-backed Neumora Therapeutics aims to raise up to $264.8 mln in US IPO

Biopharmaceutical firm Neumora
Therapeutics, backed by Amgen and Japan's SoftBank
, is aiming to raise up to $264.8 million in its U.S.
initial public offering, according to a regulatory filing...

Related Keywords

Ukraine ,Bengaluru ,Karnataka ,India ,Russia ,United States ,America ,Saumyadeb Chakrabarty ,Pritam Biswas ,Shounak Dasgupta ,Amgen ,Reuters ,Softbank ,Neumora Therapeutics ,Massachusetts Based Neumora ,Markets ,